Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical R-flurbiprofen gel safety study in people with prior non-melanoma skin cancer
ACTRN12606000192583Phase 2Completed
- Sponsor
- PharmaQest
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in non-melanoma skin cancer (NMSC) comparing R-flurbiprofen gel with Placebo gel (2 arms). Primary endpoint: Skin irritation at the site of gel application. Started Aug 2006; status: completed.
02
Drugs
tarenflurbil
03
Conditions
non-melanoma skin cancer (NMSC)
Beyond the preview
Go deeper on ACTRN12606000192583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000192583.